Gut · 1978 · 16 citations · 13 references
MedicinePharmacokineticsPharmacologyDrug MetabolismHepatic PharmacokineticsHepatologyAnthelmintic PharmacologyAntiparasitic PharmacologyDrug DispositionHepatic Drug MetabolismMedical ParasitologyPharmacokinetics In Liver DiseaseGastrointestinal Drug MetabolismHost-parasite Drug InteractionsPharmacokinetics Of Antiparasitic AgentsSubjects
The disposition of antipyrine following oral administration of 1200 mg has been investigated in 10 patients with histologically confirmed hepatosplenic schistosomiasis and 11 normal subjects living in Sudan. Drug metabolising activity as assessed by antipyrine clearance was similar in patients when compared with normal controls. We conclude that antipyrine disposition is normal in patients with clinically compensated hepatosplenic schistosomiasis.
13
A physiological approach to hepatic drug clearance
G. Wilkinson, David G. Shand · Clinical Pharmacology & Therapeutics · 1975 · 1.9K citations
THE ESTIMATION OF ANTIPYRINE IN BIOLOGICAL MATERIALS
Bernard B. Brodie, Julius Axelrod, R. K. Soberman et al. · Journal of Biological Chemistry · 1949 · 411 citations · Full text
The fate of antipyrine in man.
Bernard B. Brodie, Julius Axelrod · PubMed · 1950 · 216 citations
Determinants of serum antipyrine half-lives in patients with liver disease
Robert A. Branch, A. E. Read · Gut · 1973 · 177 citations · Full text